IP Library Patent Application 17216542
Patent Application
App. No. 17/216,542

NANOWIRE-BASED SYSTEM FOR ANALYSIS OF NUCLEIC ACIDS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/216,542
Abstract

A method for sequencing a nucleic acid template includes forming a nanowire assembly including a semiconductor nanowire and a probe covalently bound to the semiconductor nanowire; contacting the nanowire assembly with a template nucleic acid; contacting the nucleic acid duplexes with an extension nucleic acid, the extension nucleic acid joined to the probe; disrupting the nucleic acid duplexes; and measuring an electrical characteristic of a nanowire assembly of the set of nanowire assemblies.

Claims (25)

1 - 20 . (canceled)

21 . A method for sequencing a nucleic acid template, the method comprising:

forming a set of nanowire assemblies, each nanowire assembly of the set of nanowire assemblies including a semiconductor nanowire and a nucleic acid probe covalently bound to the semiconductor nanowire, the semiconductor nanowire connected at a first end to a first electrode and at a second end to a second electrode, a detector connected to the first and second electrodes to detect an electrical characteristic of the semiconductor nanowire;

contacting the set of nanowire assemblies with a template polynucleotide, the template polynucleotide at least partially complementary to the nucleic acid probe and forming a nucleic acid duplex with the nucleic acid probe;

contacting the nucleic acid duplexes with an extension nucleic acid and a ligase enzyme, the extension nucleic acid complementary to a portion of the template polynucleotide; and

measuring an electrical characteristic of a nanowire assembly.

22 . The method of claim 21 , wherein the nucleic acid probe is connected to a first binding member and the semiconductor nanowire is connected to a second binding member that specifically binds to the first binding member.

23 . The method of claim 22 , wherein the first binding member or the second binding member is streptavidin and the second binding member or the first binding member is biotin.

24 . The method of claim 22 , wherein the nucleic acid probe is connected to two of the first binding members at sites spaced along the first nucleic acid.

25 . The method of claim 24 , wherein the first binding members are spaced at opposite ends of the nucleic acid probe.

26 . The method of claim 21 , further comprising, prior to measuring an electrical characteristic, disrupting the nucleic acid duplexes to render less stable nucleic acid duplexes single stranded.

27 . The method of claim 26 , wherein disrupting includes changing a temperature of the set of nanowire assemblies.

28 . The method of claim 26 , wherein disrupting includes adjusting an ionic strength of a solution surrounding the set of nanowire assemblies.

29 . The method of claim 26 , wherein disrupting includes changing the concentration of an organic solvent.

30 . The method of claim 26 , wherein disrupting includes enzymatically disrupting.

31 . The method of claim 30 , wherein enzymatically disrupting includes adding nuclease.

32 . The method of claim 26 , wherein disrupting includes changing an electric field of a nucleic acid assembly.

33 . The method of claim 21 , wherein the step of measuring includes a step of measuring substantially no change in the electrical characteristic of a select nanowire assembly, thereby indicating that the extension nucleic acid is not added to an associated probe.

34 . The method of claim 21 , wherein the step of measuring determines a change in the electrical characteristic correlating the joining of the extension nucleic acid to the nucleic acid probe.

35 . The method of claim 21 , wherein the nucleic acid probe is a probe of a set of different probes that include regions of nucleotide sequence variation in a population.

36 . The method of claim 35 , wherein a variation in the region is disposed at or near an end of the probe.

37 . The method of claim 35 , wherein the nucleotide sequence variation corresponds to a polymorphism in a population.

38 . The method of claim 35 , wherein each nanowire assembly includes a probe of the set of different probes that is different from another probe of another nanowire assembly of the set of nanowire assemblies.

39 . The method of claim 35 , wherein the template polynucleotide includes a polymorphic region corresponding to a probe of the set of probes.

40 . The method of claim 21 , further comprising forming a second nanowire assembly including a second semiconductor nanowire and a second nucleic acid probe covalently bound to the second semiconductor nanowire, wherein the nucleic acid assembly includes the nucleic acid probe having a first region with a first nucleotide sequence variation and the second nucleic acid assembly includes the second nucleic acid probe having the region with a second nucleotide sequence variation.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2021
From: SUN, HONGYE; FUNG, STEVEN; WOO, SAM LEE
To: APPLERA CORPORATION
Reel/Frame 057263/0112 →
MERGER Recorded Aug 23, 2021
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 057263/0130 →
MERGER Recorded Aug 23, 2021
From: ATOM ACQUISITION CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 057263/0141 →
MERGER Recorded Aug 23, 2021
From: APPLIED BIOSYSTEMS INC. & ATOM ACQUISITION, LLC
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 057263/0148 →